Skip to main content
STXS logo

STXS · Stereotaxis, Inc.

Track STXS — free
$1.44 +0.06 (+4.35%) At close · Aug 20
Market Cap
$143.79M
Shares
100.20M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$1.44 Open$1.37 Day$1.36–1.45 52W close$1.26–3.57 Avg vol 30d1.2M Short int4.5M · 4.5% float · 2.5d Short vol83% Last earningsAug 11, 2026 DataJan 2020–Aug 2026 Filing10-Q · Aug 12

Up next

Next earnings call
Nov 23, 2026 Est · unconfirmed · in 13 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
filed Aug 12, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Sell
      SellHoldBuy
      Technical Sell Momentum Weak Sentiment Bearish Fundamentals Strong Quant / Vol Very High
      Market backdrop VIX 14.9 · calm Equity put/call 0.52
      Technical
      price trend
      Sell
      50 / 200-day cross No cross
      Price vs 200-day avg −29%
      below
      Price vs 50-day avg −8%
      below
      RSI (14) 49
      neutral
      MACD trend Positive
      52-week position 8%
      near low
      Momentum
      relative strength
      Weak
      1-month return +2%
      trailing
      6-month return −33%
      trailing
      YTD return −37%
      this year
      Relative strength −45%
      vs S&P · 6-mo
      Sentiment
      smart money
      Bearish
      Trend (MA cross) No cross
      50d $2 › 200d $2 — 200d above 50d
      Institutional flow Distributing
      -9% holders QoQ · +12 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      4.47% of float · ▲ +0.5% MoM · 2.5 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      107 holders — mid 3-yr range
      Squeeze score 56
      elevated · 0–100
      Fundamentals
      Strong
      Revenue growth −6%
      Y/Y
      Gross margin 58%
      expanding
      EPS growth +17%
      Y/Y
      Balance sheet $12.4M
      net cash
      Quant / Vol
      risk profile
      Very High
      Volatility 53%
      annualized · 1-yr
      Max drawdown −65%
      past year
      ATR 6.5%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the 8-K filed Aug 11, 2026
      third quarter of this year
      Recurring revenue $7M
      System revenue $3M
      fourth quarter of this year
      System revenue $3M
      Prior guidance period ended · from the 8-K filed Nov 12, 2025
      Revenue · fourth quarter of this year at least $9M
      Recurring revenue · fourth quarter of this year at least $6M
      Guided vs delivered · last 1 settled
      Revenue fourth quarter of this year
      guided at least $9M
      $8.64M Miss −4.0%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Sell
      3 · 2 · 1
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      −29% Bearish
      Price vs 50-day avg
      −8% Bearish
      RSI (14)
      49 Neutral
      MACD trend
      Positive Bullish
      52-week position
      8% Bearish
      Market signals — smart money & positioning
      Bearish · 2 of 6
      Trend (MA cross) No cross
      50d $2 › 200d $2 — 200d above 50d
      Institutional flow Distributing
      -9% holders QoQ · +12 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      4.47% of float · ▲ +0.5% MoM · 2.5 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      107 holders — mid 3-yr range
      Price context
      position in its 52-week range
      Range low $1 Now $1 · 8% Range high $4
      vs 200-day avg -29% vs 50-day avg -8%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Free cash flow -$3.7M Q2 2026
      System backlog $9.1M the start of 2026

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Medical Instruments & Supplies — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      STXS
      Stereotaxis, Inc.
      this stock
      $143.79M -37.4% -5.8% 4.5%
      ISRG
      Intuitive Surgical Inc
      $140.51B -33.9% +20.5% 45.7 1.9%
      BDX
      Becton Dickinson & Co
      $49.24B +8.2% 3.7%
      MDLN
      Medline Inc.
      $44.58B -22.4% +11.5% 2.6%
      ALC
      Alcon Inc
      $35.25B -7.5% +10.5% 2.8%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Reducing
      Holders
      107
      % held
      42.5%
      Net QoQ
      -471.1K sh
      Top holder
      DAFNA Capital Management…
      Held Float
      View
      Held by Funds
      Fund positions
      85
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      4.5M
      Days to cover
      2.5d
      Change
      +23.9K sh
      View
      Short Volume
      Short vol %
      83%
      As of
      Aug 20, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      173
      Value
      $230
      As of
      Jul 31, 2026
      View
      Off-Exchange
      Off-exchange %
      60.3%
      Week of
      Jul 13, 2026
      Off-exch Lit
      View
      Financials
      Financials
      Revenue (FY)
      $32.4M
      Net income (FY)
      $-21.6M
      EPS diluted
      $-0.25
      View
      Filings
      SEC Filings
      Latest
      10-Q
      Filed
      Aug 12, 2026
      This year
      12
      View
      Exempt Offerings
      Offering
      Indefinite
      Filed
      Aug 15, 2024
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 11, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      STXS +4.4% +2.1% -33.3% +14.3% -37.4%
      SPY -2.0% +3.3% +11.2% +2.1% +11.8%
      vs SPY +6.3% -1.2% -44.5% +12.2% -49.2%
      Key facts CIK 1289340 CUSIP 85916J409 13F (30d) 99 filings 99 filers Visit website Investor relations